Jean Claude do-Rego

researcher

Jean Claude do-Rego is …
instance of (P31):
humanQ5

External links are
P5552CNRS Talent pagejean-claude-do-rego
P973described at URLhttps://www.cnrs.fr/fr/personne/jean-claude-do-rego

P166award receivedCNRS Crystal medalQ3002813
P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q37364000A role for intestinal TLR4-driven inflammatory response during activity-based anorexia
Q24599636Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans
Q45197422Anti-neuropeptide Y plasma immunoglobulins in relation to mood and appetite in depressive disorder
Q79845785Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice
Q48249692Antinociceptive and antidepressant-like action of endomorphin-2 analogs with proline surrogates in position 2.
Q28269772Behavioral actions of urotensin-II
Q42667921Behavioral effects of urotensin-II centrally administered in mice
Q42164059Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2.
Q45180464Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modified in the third position.
Q46960010Comparisons between anxiety tests for selection of anxious and non anxious mice
Q42732860Correction for "Synthesis of Mixed Opioid Affinity Cyclic Endomorphin-2 Analogues with Fluorinated Phenylalanines".
Q39296580Design, synthesis and pharmacological characterization of endomorphin analogues with non-cyclic amino acid residues in position 2.
Q63249355Effect of 2′,6′-dimethyl-l-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs
Q48820591Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice
Q37251392Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders
Q28550357French Intensive Care Society, International congress - Réanimation 2016
Q40259394Gut Commensal E. coli Proteins Activate Host Satiety Pathways following Nutrient-Induced Bacterial Growth
Q36655222Hypericum caprifoliatum (Guttiferae) Cham. & Schltdl.: a species native to South Brazil with antidepressant-like activity
Q37124526Increased Ghrelin but Low Ghrelin-Reactive Immunoglobulins in a Rat Model of Methotrexate Chemotherapy-Induced Anorexia
Q35985375Kinetic studies of novel inhibitors of endomorphin degrading enzymes
Q36610759Maintaining physical activity during refeeding improves body composition, intestinal hyperpermeability and behavior in anorectic mice
Q46624328Modifications in avoidance reactions of mice, on a second exposure to the hot plate, resist to various amnesia-inducing treatments
Q43921739Mouse lines differing in sensitivity to beta-CCM differ in tasks used for testing antidepressants
Q39908953Novel endomorphin analogues with antagonist activity at the mu-opioid receptor in the gastrointestinal tract
Q44337532Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure
Q38710203Opioid and Cannabinoid System in Food Intake
Q44345880Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs
Q50802363Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues.
Q44339188Pharmacological properties of novel cyclic pentapeptides with µ-opioid receptor agonist activity
Q46399968Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.
Q34702087Potential of olfactory ensheathing cells from different sources for spinal cord repair
Q34848266Regulation of feeding and anxiety by alpha-MSH reactive autoantibodies
Q44803175Repeated administration of an aqueous spray-dried extract of the leaves of Passiflora alata Curtis (Passifloraceae) inhibits body weight gain without altering mice behavior
Q40423267Sex differences in response to activity-based anorexia model in C57Bl/6 mice.
Q35564817Sex-related effects of nutritional supplementation of Escherichia coli: relevance to eating disorders
Q43170583Structural and pharmacological characteristics of chimeric peptides derived from peptide E and beta-endorphin reveal the crucial role of the C-terminal YGGFL and YKKGE motifs in their analgesic properties
Q46708649Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs
Q48384974Synthesis and biological evaluation of cyclic endomorphin-2 analogs
Q48217158Synthesis and biological evaluation of novel peripherally active morphiceptin analogs
Q44333625Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
Q35615157Synthesis of mixed opioid affinity cyclic endomorphin-2 analogues with fluorinated phenylalanines
Q37727696The Spontaneous Autoimmune Neuromyopathy in ICOSL-/- NOD Mice Is CD4+ T-Cell and Interferon-γ Dependent
Q46615568The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake
Q36747911The endomorphin system and its evolving neurophysiological role
Q43067753The novel endomorphin degradation blockers Tyr-Pro-DClPhe-Phe-NH (EMDB-1) and Tyr-Pro-Ala-NH (EMDB-2) prolong endomorphin-2 action in rat ileum in vitro
Q44334395Uliginosin B presents antinociceptive effect mediated by dopaminergic and opioid systems in mice
Q28254994Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs
Q28287953Urotensin II, from fish to human
Q44337660[Dmt1, d-1-Nal3]morphiceptin, a novel opioid peptide analog with high analgesic activity

Search more.